pharmaphorum
MAY 24, 2021
Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The three-country poll found that Spain is way out in front, with over half of people asked responding that digital is already playing a major role in the networking of healthcare facilities, diagnosing illnesses and telemedicine.
Outsourcing Pharma
MAY 24, 2021
The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MAY 26, 2021
Laura Dix, Managing Director, Life Sciences, UK breaks down ‘5 ingredients’ that are sure to make a positive impact in the interaction between pharma marketers and healthcare professionals (HCPs). COVID-19 drastically changed the playing field of HCP communication and engagement. Dix reminds us that the time has never been so important to truly differentiate when creating high-quality experiences for HCPs – experiences that HCPs deserve and will crave more of in the future when treating p
Pharma Times
MAY 24, 2021
First one-time gene therapy for CALD among latest recommendations
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 28, 2021
Is collecting near real time data the key to unlocking improvements in patient experience and national benchmarking? Small things can go a long way in terms of improving patient experience, but healthcare facilities cannot fix what they don’t know is broken. In the first of our series of articles from the Patient Experience: Empathy and Innovation Digital Summit, we look at how uncovering actionable data through simple feedback surveys can boost organisations’ standing on the national stage.
Outsourcing Pharma
MAY 27, 2021
Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
MAY 28, 2021
Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis
pharmaphorum
MAY 27, 2021
Concert Pharmaceuticals has started the second of two planned phase 3 trials of its drug candidate for alopecia areata (AA), a common cause of hair loss, and says it hopes to report results in the second half of 2022. The two studies – THRIVE-AA1 and THRIVE-AA2 – are testing oral JAK1/2 inhibitor CTP-543 in adults with moderate-to-severe AA, an autoimmune disease that leads to loss of hair in patches on scalp and body.
Outsourcing Pharma
MAY 25, 2021
With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies.
Policy Prescription
MAY 28, 2021
For the past decade, I’ve written extensively about my view that pharma-funded organizations and initiatives are responsible for misleading Americans about the safety of buying more affordable prescription drugs over the Internet for import from Canada and other countries. Most of that writing was on PharmacyCheckerBlog – but periodically it shows up in national media, including in the New York Times back in 2014, and more recently this past February The Hill.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
MAY 26, 2021
Once-daily oral treatment was well-tolerated and demonstrated a good safety profile in Phase IIb study
pharmaphorum
MAY 24, 2021
Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. It is a newer concept for pharma marketers, however, who are now turning to modular solutions in response to the accelerated demand for content over the past year.
Outsourcing Pharma
MAY 25, 2021
Acting FDA commissioner Janet Woodcock explains how government, researchers, doctors and patients can contribute to improving the clinical research system.
Pharma Mirror
MAY 28, 2021
If you are trying to set up your own laboratory, then you should prepare for a myriad of expenses. Budgeting is a process that is required throughout the running of your lab. It keeps everything in order and ensures the continued efficiency of whatever operation or experiment you are overseeing. Without the proper financial backing, things may quickly fall apart soon after.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
MAY 24, 2021
At six and a half years 49% of patients treated with combination therapy remained alive
pharmaphorum
MAY 25, 2021
With the ink barely dry on the FDA’s approval of Johnson & Johnson’s Rybrevant, its first bispecific antibody for cancer, the drugmaker is already showcasing others in its pipeline. . Two of its earlier-stage bispecifics – both in development for the blood cancer multiple myeloma – will feature at the American Society of Clinical Oncology (ASCO) congress, which kicks off in a few days’ time.
Outsourcing Pharma
MAY 24, 2021
According to a leader from the pharma firm, considering a patientâs needs and seeing them as a whole person is vital to successful studies and drug design.
Mission-Driven Marketing Blog
MAY 27, 2021
If the global pandemic has taught us anything, it is that so much of our nonprofit work can be done online. Over the past year, we have seen galas, 5ks, auctions, and annual fundraisers adapt to being virtual. But where does social media fit into it all?
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
MAY 24, 2021
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing
pharmaphorum
MAY 27, 2021
Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with uterine fibroids. . The drug will be sold as Myfembree (relugolix) for the uterine fibroids indication, and is already available to treat prostate cancer under the Orgovyx brand name.
Pharma Mirror
MAY 27, 2021
The second week of CPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both CPhI Worldwide and Pharmapack Europe. The last year has seen pharma evolve its approach to meeting new partners and existing customers, with wider pools of suppliers now needed, and remote and virtual networking being used to begin conversations much earlier than in the past.
Outsourcing Pharma
MAY 27, 2021
A panel of experts at the online pharma event discussed how the pandemic created opportunities for the field but could also lead to significant challenges.
Pharma Times
MAY 25, 2021
Vaccine candidate demonstrated 83.
pharmaphorum
MAY 26, 2021
Paula Parfitt discusses the importance of workplace diversity and how life science companies can build a thriving, diverse workforce. Diversity, equity and inclusion (D, E & I) is a sensible business choice with significant commercial benefits. A homogenous workforce has a smaller pool of collective experience, meaning that when problems arise, collective creativity and innovation is muted.
Pharma Marketing Network
MAY 26, 2021
[link]. The post DarshanTalks: Patient Advocacy and Conflicts of Interest</br> – May 26, 2021 appeared first on Pharma Marketing Network.
Outsourcing Pharma
MAY 27, 2021
Created by an industry veteran with more than 20 yearsâ experience, Protodigm aims to offer innovation and expertise to pharmaceutical industry clients.
Druggist
MAY 22, 2021
Gaviscon is (most likely) the most well-known brand of liquid antacid. Antacids are used to relieve symptoms of heartburn and indigestion (dyspepsia). Heartburn is a common symptom experienced during pregnancy. Today I will look into the use of Gaviscon in pregnancy by looking at the main recommendations of heartburn treatment in pregnancy. I will conclude which particular Gaviscon product is the best to use in the pregnancy. .
pharmaphorum
MAY 26, 2021
A UK tech firm with an NHS-commissioned mental health app – Hello Tomo – has been acquired by ICAS World, a company specialising in providing employee health and wellbeing services. . Hello Tomo is described as a behaviour change tool for mental health and wellbeing that aims to help users maintain healthy habits, and according to ICAS is the first of a series of acquisitions underpinning a new digital health strategy at the group.
Pharma Times
MAY 27, 2021
Once-daily treatment has been approved for the management of heavy menstrual bleeding
Outsourcing Pharma
MAY 25, 2021
The medical device tech firm is poised to assist manufacturers in navigating the new European Medical Device Regulation, which goes into effect this week.
Med Ed 101
MAY 26, 2021
I got asked a question the other day about spironolactone. Specifically, how common is gynecomastia with spironolactone? Before I answer that question, let’s take a look at some of the common clinical pearls with spironolactone. Spironolactone classified as a potassium-sparing diuretic, so from that description, we know that we have to monitor for the risk […].
pharmaphorum
MAY 25, 2021
The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to wider adoption. These challenges often arise because these therapies go through the same value assessment processes as less complex medicines, and the infrastructure needed to administer them to the right patients isn’t yet widely available. .
Pharma Times
MAY 27, 2021
Strategy “marks a shift away from organisations and towards service improvement”
Expert insights. Personalized for you.
144 
Let's personalize your content